Search Results 441-450 of 16786 for Fibronolytic

  1. A Study to Collect Clinical Data and Store Samples of Blood and Tissue for Current and Future Research Studies on Sarcoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Pulmonary Hypertension Association Registry - Mayo Clinic

    About this study. The PHAR is a multicenter, prospective registry of newly evaluated patients at PHCCs in the United States who have either PAH or CTEPH.

  3. Study Is To Assess The Safety And Tolerability Of VTx-002 In Participants With ALS - Mayo Clinic

    PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose, uncontrolled, first-in-human study that will evaluate the safety, tolerability and effects ...

  4. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  5. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to validate candidate universal and site-specific methylated DNA markers (MDMs) in DNA extracted from formalin-fixed paraffin ...

  6. Univentricular Heart Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine if the medication, sildenafil (also known as Revatio), can slow or stop the progression of liver disease in patients ...

  7. Functional Outcome in Patients with Subarachnoid Hemorrhage - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. https://www.mayoclinic.org/london.xml

  9. A Study to Evaluate the Burden of Treatment and Illness in Advanced Heart Failure Patients - Mayo Clinic

    The primary purpose of this study is to identify which aspects of treatment are most prevalent and burdensome to patients with advanced heart failure.

  10. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

    About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...